Blonder Tongue Bringing SRT to Best-Selling Aircaster® AQT8 Series


Share this page:

Las Vegas, NV and Old Bridge, N.J. — April 17, 2023 — Blonder Tongue Laboratories, Inc. (OTCQB: BDRL), a leading US-based designer and manufacturer of telecommunications, broadband, and fiber optic transmission technologies, announced today its best-selling transmodulators, the Aircaster® AQT8 Series, will now offer SRT Error Correction for Remote IP/QAM Applications.

Aircaster AQT8-QAM/IP (Front and Back View Photo)

The newly implemented SRT transmit functionality allows the Aircaster AQT8 transmodulators to be used at remote receive sites. This configuration supports secondary or redundant program ingest capability and enables operators to receive fringe stations more clearly from remote receiver locations.

“Blonder Tongue is committed to reducing our customers’ overall system cost with innovation and ingenuity,” said Tim Buck, Senior Vice President, Sales and Marketing. “SRT is a great option that enables remote equipment deployment without the expense of dedicated fiber and provides the ultimate flexibility to the transport capabilities of the Aircaster AQT8 series.”

The addition of SRT to the Aircaster AQT8 series follows along with Blonder Tongue’s previously announced Clearview HDMI2 QAM IP and Clearview HD2X QAM IP encoders. The addition of SRT across Blonder Tongue’s product offerings will give Broadcasters the ability to process programs safely across the public Internet for point-to-point applications. These SRT-enabled devices can effectively reduce the costs of dedicated fiber backhauling, while also allowing operators the flexibility they need to provide redundant sources, eliminating single point of failure concerns as well.

See Blonder Tongue Laboratories at NABSHOW 2023 in Booth W3316.

For more information, please visit:

About Blonder Tongue

Blonder Tongue Laboratories, Inc. is the oldest designer and manufacturer of telecommunications and cable television video transmission technology in the USA. The majority of its products continue to be designed and built in their state-of-the-art New Jersey facility, which has been the Company’s home for more than 50 years. Blonder Tongue Labs offers U.S.-based engineering and manufacturing excellence with an industry reputation for delivering ultra-high reliability products. As a leader in cable television system design, the Company provides service operators and systems integrators with comprehensive solutions for the management and distribution of digital video, IPTV, and high-speed data services, as well as RF broadband distribution over fiber, IP, and Coax networks for homes and businesses. Additional information on the Company and its products can be found at
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: The information set forth above includes “forward-looking” statements and accordingly, the cautionary statements contained in Blonder Tongue’s Annual Report and Form 10-K for the year ended December 31, 2021 (See Item 1: Business, Item 1A: Risk Factors, Item 3: Legal Proceedings and Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations), and other filings with the Securities and Exchange Commission are incorporated herein by reference. All statements, other than those of historical fact, which address activities, events, outcomes, results, developments, performance or achievements that Blonder Tongue anticipates or expects may or will occur in the future should be considered "forward-looking" statements, including statements that use the words “believe”, “expect”, “anticipate”, “project”, “target”, “intend”, “plan”, “seek”, “estimate”, “endeavor”, “should”, “could”, “may” and similar expressions. In addition, any statements that refer to projections for our future financial performance, our anticipated growth trends in our business and other characterizations of future events or circumstances are forward-looking statements, including statements regarding our ability to continue as a going concern. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. Blonder Tongue undertakes no obligation to publicly revise or update these forward-looking statements to reflect events or circumstances that arise after the date hereof. Blonder Tongue’s actual results may differ from the anticipated results or other expectations expressed in Blonder Tongue’s “forward-looking” statements.


Blonder Tongue Laboratories